A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants
Clinical trial NCT06088784 · COMPLETED
Trial details
- NCT number
- NCT06088784
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2024-04-24
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.